CA26514-2 - 0x0000000000003A09

Study Number: CA26514
Group Number: 2
Study Requirement: Healthy Normal Male and Female
Stipend: up to £ 4,800

Study Criteria:

  • Age: 18 - 55
  • BMI: 19 - 30
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat cystic fibrosis
  • Route of Administration: Oral
  • Blood Draws: 59

Study Schedule:

  • Schedule Type: Long Term
  • Study Length: One - 27 Night Stay & 4 Returns

Screening Dates:

Event Day Event Date Site
Tuesday Jan 8 2019 Belfast
Wednesday Jan 9 2019 Belfast

Doctor Exam Dates:

Event Day Event Date Site
Tuesday Jan 8 2019 Belfast
Wednesday Jan 9 2019 Belfast

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Saturday Jan 19 2019 10:00AM Friday Feb 15 2019 7:45AM 1 Belfast
Return Thursday Feb 21 2019 6:30AM Thursday Feb 21 2019 7:45AM 1 Belfast
Return Thursday Feb 28 2019 6:30AM Thursday Feb 28 2019 7:45AM 1 Belfast
Return Thursday Mar 7 2019 6:30AM Thursday Mar 7 2019 7:45AM 1 Belfast
Return Thursday Mar 14 2019 6:30AM Thursday Mar 14 2019 7:45AM 1 Belfast